Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
95.87
-0.27 (-0.28%)
At close: Nov 14, 2025, 4:00 PM EST
95.90
+0.03 (0.03%)
After-hours: Nov 14, 2025, 7:56 PM EST
Medtronic Revenue
Medtronic had revenue of $8.58B in the quarter ending July 25, 2025, with 8.38% growth. This brings the company's revenue in the last twelve months to $34.20B, up 4.98% year-over-year. In the fiscal year ending April 25, 2025, Medtronic had annual revenue of $33.54B with 3.62% growth.
Revenue (ttm)
$34.20B
Revenue Growth
+4.98%
P/S Ratio
3.60
Revenue / Employee
$360,000
Employees
95,000
Market Cap
122.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 26, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 27, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MDT News
- 4 days ago - Minze Health Announces Collaboration with Medtronic to Support Patients with Overactive Bladder in EMEA - Business Wire
- 4 days ago - Medtronic: Possible Earnings Beat Incoming But Still Overvalued - Seeking Alpha
- 5 days ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 10 days ago - Medtronic to announce financial results for its second quarter of fiscal year 2026 - PRNewsWire
- 13 days ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire
- 15 days ago - Best Dividend Aristocrats For November 2025 - Seeking Alpha
- 18 days ago - U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system - PRNewsWire
- 20 days ago - Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions - PRNewsWire